|
|
|
40
|
0141GB
|
EZECURE 500MG TAB (EMC/COL) AZITHROMYCIN
|
AZITHROMYCIN
|
EZECURE
|
3'S
|
A
|
1.39
|
0.46
|
TABLET
|
7
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08121292
|
OTHER MACROLIDES
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
40
|
0141HA
|
EZECURE 500MG TAB (EMC/COL) AZITHROMYCIN
|
AZITHROMYCIN
|
EZECURE
|
60'S
|
A
|
27.80
|
0.46
|
TABLET
|
7
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08121292
|
OTHER MACROLIDES
|
2022-08-10
|
2024-03-31
|
Package Size Change
|
oral
|
0
|
ANTI-INFECTIVE AGENTS
|
2022-08-10
|
|
|
|
40
|
0211AA
|
EMSTAR 500MG INJ (EMC/COL) MEROPENEM
|
MEROPENEM
|
EMSTAR
|
500MG VIAL
|
BQ
|
9.51
|
9.51
|
INJECTION
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0211AA
|
EMSTAR 500MG INJ (EMC) MEROPENEM (C)
|
MEROPENEM
|
EMSTAR
|
500MG VIAL
|
C
|
10.87
|
10.8733
|
VIAL
|
42
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120708
|
CARBAPENEMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
2
|
CARBAPENEMS
|
|
|
|
|
42
|
0211AA
|
EMSTAR 500MG INJ (EMC) MEROPENEM
|
MEROPENEM
|
EMSTAR
|
500MG VIAL
|
BQ
|
6.42
|
6.42
|
VIAL
|
42
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
08120708
|
CARBAPENEMS
|
2026-04-01
|
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
40
|
0212AV
|
EMSTAR 1G INJ (EMC/COL) MEROPENEM
|
MEROPENEM
|
EMSTAR
|
1G VIAL
|
BQ
|
10.87
|
10.87
|
INJECTION
|
0
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120708
|
CARBAPENEMS
|
2022-04-01
|
2024-03-31
|
|
IV
|
6
|
ANTI-INFECTIVE AGENTS
|
|
|
|
|
41
|
0212AV
|
EMSTAR 1G INJ (EMC) MEROPENEM (C)
|
MEROPENEM
|
EMSTAR
|
1G VIAL
|
C
|
12.23
|
12.2325
|
VIAL
|
42
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
08120708
|
CARBAPENEMS
|
2024-04-01
|
2026-03-31
|
|
IV
|
2
|
CARBAPENEMS
|
|
|
|
|
42
|
0212AV
|
EMSTAR 1G INJ (EMC) MEROPENEM
|
MEROPENEM
|
EMSTAR
|
1G VIAL
|
BQ
|
7.77
|
7.77
|
VIAL
|
42
|
VIAL
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
08120708
|
CARBAPENEMS
|
2026-04-01
|
|
|
IV
|
0
|
CARBAPENEMS
|
|
|
|
|
40
|
1131DQ
|
ATOREC 10MG TAB (EMC/COL) ATORVASTATIN
|
ATORVASTATIN
|
ATOREC
|
30'S
|
C
|
3.26
|
0.11
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
42
|
1131DQ
|
ATOREC 10MG TAB (EMC) ATORVASTATIN (C)
|
ATORVASTATIN
|
ATOREC
|
30'S
|
C
|
3.53
|
0.12
|
TAB
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
HMG-CoA REDUCTASE INHIBITORS
|
|
|
|
|
40
|
1132EM
|
ATOREC 20MG TAB (EMC/COL) ATORVASTATIN
|
ATORVASTATIN
|
ATOREC
|
30'S
|
C
|
3.81
|
0.13
|
TABLET
|
0
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
0
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1132FV
|
CONSIVAS 10MG TAB (EMC/COL) ROSUVASTATIN
|
ROSUVASTATIN
|
CONSIVAS
|
100'S
|
A
|
13.05
|
0.13
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
1133EG
|
CONSIVAS 20MG TAB (EMC/COL) ROSUVASTATIN
|
ROSUVASTATIN
|
CONSIVAS
|
100'S
|
A
|
14.87
|
0.15
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
240608
|
HMG-CoA REDUCTASE INHIBITORS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
CARDIOVASCULAR DRUGS
|
|
|
|
|
40
|
3921K
|
ANTIPLAR 75MG TAB (EMC/COL) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
9.51
|
0.10
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2022-05-31
|
2022-12-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
2022-05-31
|
|
|
|
41
|
3921K
|
ANTIPLAR 75MG TAB (EMC) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
8.7
|
0.087
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
42
|
3921K
|
ANTIPLAR 75MG TAB (EMC) CLOPIDOGREL
|
CLOPIDOGREL
|
ANTIPLAR
|
100'S
|
A
|
8.70
|
0.09
|
TAB
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
201218
|
PLATELET AGGREGATION INHIBITORS
|
2026-04-01
|
|
|
ORAL
|
6
|
PLATELET AGGREGATION INHIBITORS
|
|
|
|
|
40
|
49513
|
OROFER CHEWABLE 350MCG | 100MG TAB (EMC/COL) FO
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER CHEWABLE
|
30'S
|
A
|
5.44
|
0.18
|
TABLET
|
30
|
TAB
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|
|
|
|
41
|
49513
|
OROFER CHEWABLE 350MCG|100MG TAB (EMC) F
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER CHEWABLE
|
30'S
|
A
|
6.12
|
0.2039
|
TAB
|
30
|
BOX
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2024-04-01
|
2026-03-31
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
42
|
49513
|
OROFER 350MCG|100MG CHEW TAB (EMC) FOLIC ACID|IRON 3 HYDROXY
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
30'S
|
A
|
9.79
|
0.33
|
TAB
|
30
|
BLIS
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
AVENTA BARBADOS
|
|
200404
|
IRON PREPARATIONS
|
2026-04-01
|
|
|
ORAL
|
6
|
IRON PREPARATIONS
|
|
|
|
|
40
|
49514
|
OROFER 550MCG | 100MG CAP (EMC/COL) FOLIC ACID |
|
FOLIC ACID|IRON 3 HYDROXY POLYMALTOSE
|
OROFER
|
40'S
|
A
|
4.08
|
0.10
|
CAPSULE
|
30
|
CAP
|
EMC
|
EMCURE PHARMACEUTICALS LTD
|
COL
|
COLLINS LTD
|
|
200404
|
IRON PREPARATIONS
|
2022-04-01
|
2024-03-31
|
|
Oral
|
6
|
BLOOD FORMATION, COAGULATION AND THROMBOSIS
|
|